GlaxoSmithKline PLC is selling its remaing rights to an autoimmune disease treatment to Novartis AG. "Glaxa Sells Rights to Auto-Immune Drug to Novartis," at 0934 GMT, misspelled Glaxo's name in the headline.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

August 21, 2015 09:11 ET (13:11 GMT)

Copyright (c) 2015 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Gsk Charts.